Literature DB >> 28003967

Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Fang Hou1, Qi-Ming Huang1, Dan-Ning Hu2, Jost B Jonas3, Wen-Bin Wei1.   

Abstract

AIM: To examine the genetic profile of primary uveal melanoma (UM) as compared to UM in immune escape.
METHODS: Dendritic cells (DC) loaded with lysates of UM cells of high metastatic potential were used to stimulate CTLs(CTLs). When CTLs co-cultured with the UM cells, most UM cells could be eliminated. Survival UM cells grew slowly and were considered to be survival variants and examined by a microarray analysis. These differential genes were analyzed further with Venn Diagrams and functions related to immune escape. We additionally examined transcriptional changes of manually selected survival variants of UM cells and of clinical UM samples by quantitative real-time polymerase chain reaction (qRT-PCR), and analyzed the correlation of these expressions and patients' survival.
RESULTS: Gene expression analyses revealed a marked up-regulation of SLAMF7 and CCL22 and a significant down-regulation of KRT10, FXYD3 and ABCC2. The expression of these genes in the relapsed UM was significantly greater than those in primary UM. UM patients with overexpression of these genes had a shorter survival period as compared with those of their underexpression.
CONCLUSION: Gene expression, in particular of SLAMF7, CCL22, KRT10, FXYD3 and ABCC2, differed between primary UM cells and survival variants of UM cells.

Entities:  

Keywords:  SLAMF7; dendritic cells; gene expression profile; immune escape; uveal melanoma

Year:  2016        PMID: 28003967      PMCID: PMC5154980          DOI: 10.18240/ijo.2016.12.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  48 in total

1.  Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape.

Authors:  Mónica Bernal; Fernando García-Alcalde; Angel Concha; Carlos Cano; Armando Blanco; Federico Garrido; Francisco Ruiz-Cabello
Journal:  Cancer Immunol Immunother       Date:  2011-11-10       Impact factor: 6.968

Review 2.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.

Authors:  Stephan Meding; Benjamin Balluff; Mareike Elsner; Cédrik Schöne; Sandra Rauser; Ulrich Nitsche; Matthias Maak; Alexander Schäfer; Stefanie M Hauck; Marius Ueffing; Rupert Langer; Heinz Höfler; Helmut Friess; Robert Rosenberg; Axel Walch
Journal:  J Pathol       Date:  2012-05-23       Impact factor: 7.996

Review 4.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

5.  Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor.

Authors:  Yang-Hwan Ryu; Jae-Chan Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

6.  Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.

Authors:  Je-Jung Lee; Bo-Hwa Choi; Hyun-Kyu Kang; Myong-Suk Park; Jung-Sun Park; Sang-Ki Kim; Thanh-Nhan Nguyen Pham; Duck Cho; Jong-Hee Nam; Young-Jin Kim; Joon-Haeng Rhee; Deok-Hwan Yang; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Ik-Joo Chung
Journal:  Leuk Lymphoma       Date:  2007-10

7.  Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.

Authors:  Jürgen Haas; Laila Schopp; Brigitte Storch-Hagenlocher; Benedikt Fritzsching; Christian Jacobi; Linda Milkova; Brigitte Fritz; Alexander Schwarz; Elisabeth Suri-Payer; Manfred Hensel; Brigitte Wildemann
Journal:  Blood       Date:  2007-10-29       Impact factor: 22.113

8.  A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.

Authors:  Stéphanie Bibert; David Aebischer; Florian Desgranges; Sophie Roy; Danièle Schaer; Solange Kharoubi-Hess; Jean-Daniel Horisberger; Käthi Geering
Journal:  Mol Biol Cell       Date:  2008-12-24       Impact factor: 4.138

9.  Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma.

Authors:  C S Vetter; W Lieb; E-B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways.

Authors:  Balaji Balasa; Rui Yun; Nicole A Belmar; Melvin Fox; Debra T Chao; Michael D Robbins; Gary C Starling; Audie G Rice
Journal:  Cancer Immunol Immunother       Date:  2014-10-07       Impact factor: 6.968

View more
  3 in total

1.  Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.

Authors:  Andrea Soltysova; Tatiana Sedlackova; Dana Dvorska; Karin Jasek; Pooneh Chokhachi Baradaran; Viera Horvathova Kajabova; Lucia Demkova; Verona Buocikova; Terezia Kurucova; Darina Lyskova; Alena Furdova; Gabriel Minarik; Pavel Babal; Zuzana Dankova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

2.  CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma.

Authors:  Arjun Khunger; Erin Piazza; Sarah Warren; Thomas H Smith; Xing Ren; Andrew White; Nathan Elliott; Alessandra Cesano; Joseph M Beechem; John M Kirkwood; Ahmad A Tarhini
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

3.  Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.

Authors:  Hui Pan; Linna Lu; Junqi Cui; Yuan Yang; Zhaoyang Wang; Xianqun Fan
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.